Literatur
RKI.(2011) Final presentation and evaluation of the epidemiological findings in the EHEC O104:H4 outbreak, Germany 2011. http://www.rki.de/EN/Home/EHEC_final_report.pdf?__blob=publicationFile.
Menne J, Nitschke M, Stingele R et al (2012) Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study. BMJ 345:e4565
Corogeanu D, Willmes R, Wolke M et al (2012) Therapeutic concentrations of antibiotics inhibit Shiga toxin release from enterohemorrhagic E. coli O104:H4 from the 2011 German outbreak. BMC Microbiol 12:160
Nitschke M, Sayk F, Härtel C et al (2012) Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4. JAMA 307:1046–1052
McGannon CM, Fuller CA, Weiss AA. (2010) Different classes of antibiotics differentially influence shiga toxin production. Antimicrob. Agents Chemother 54:3790–3798
Einhaltung der ethischen Richtlinien
Interessenkonflikt. U. Klinger und H. Dormann geben an, dass kein Interessenkonflikt besteht. Das vorliegende Manuskript enthält keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Klinger, U., Dormann, H. Azithromycin bei EHEC. Notfall Rettungsmed 16, 460–461 (2013). https://doi.org/10.1007/s10049-013-1740-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10049-013-1740-8